Dupilumab is a monoclonal antibody against the a subunit of the receptor for interleukin 4 and interleukin 13. It is the first biological drug registered in the world for the treatment of atopic dermatitis. Dupilumab turned out to be a milestone in the treatment of atopic dermatitis and an alternative to standard immunosuppressive drugs. https://www.bekindtopets.com/top-price-Gemplers-4-mil-Disposable-Nitrile-Gloves-Bucket-of-1000-Gloves-p8887-huge-savings/